The Mosaic Company Earnings Call Transcripts
Fiscal Year 2025
-
Fourth quarter 2025 saw weak U.S. phosphate demand and margin pressure from high sulfur prices, but operational improvements, cost savings, and asset divestitures position the company for a stronger 2026 with higher phosphate and potash production and improved cash flow as working capital unwinds.
-
Q3 saw strong net income and EBITDA growth, driven by higher prices and robust Brazil and potash performance. Asset health investments improved phosphate output, while cost savings and capital reallocation advanced. 2026 is expected to bring significant cash flow improvement.
-
Q2 saw a return to profitability with $411M net income, driven by improved operations, cost reductions, and favorable market conditions. Guidance was raised for potash production, and strong earnings growth is expected in H2 2025 as maintenance projects conclude and market fundamentals remain robust.
-
Q1 2025 saw strong net income and EBITDA, driven by robust phosphate and potash prices, exceptional Brazil performance, and rapid growth in biosciences. Operational improvements and cost reductions are on track, with positive market fundamentals and tight supply supporting elevated margins.
-
The company is executing a new strategy focused on operational reliability, capital reallocation, and leveraging market access and biosciences for growth. Phosphate and potash markets are expected to remain tight, supporting strong pricing, while digital transformation and innovation in biologicals drive margin expansion and cash flow.
Fiscal Year 2024
-
Q4 2024 saw $169M net income and $594M adjusted EBITDA, with strong phosphate and potash performance and robust results in Brazil. Strategic asset sales, cost reductions, and a positive 2025 outlook were highlighted, despite FX losses and supply constraints.
-
Q3 results showed resilience amid storms and production issues, with $2.8B revenue and $122M net income. Phosphate margins remain strong, potash prices are rebounding, and 2025 demand outlook is positive. Cost savings and capital discipline continue to support growth.
-
Q2 2024 saw lower year-over-year earnings but strong operational progress, with cost reductions, robust global fertilizer demand, and continued capital returns to shareholders. Phosphate and potash markets remain constructive, and production ramp-ups are on track for 2024 targets.